Copyright Reports & Markets. All rights reserved.

Global Antifungal infection Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Polyenes
      • 1.4.3 Echinocandins
      • 1.4.4 Azoles
      • 1.4.5 Allylamines
      • 1.4.6 Other Drug types
    • 1.5 Market by Application
      • 1.5.1 Global Antifungal infection Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Powders
      • 1.5.3 Pastes
      • 1.5.4 Ointments
      • 1.5.5 Drugs
      • 1.5.6 Other Applications
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antifungal infection Therapeutics Market Size
    • 2.2 Antifungal infection Therapeutics Growth Trends by Regions
      • 2.2.1 Antifungal infection Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Antifungal infection Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Antifungal infection Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Antifungal infection Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antifungal infection Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Antifungal infection Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Antifungal infection Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antifungal infection Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Antifungal infection Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Antifungal infection Therapeutics Market Size (2014-2019)
    • 5.2 Antifungal infection Therapeutics Key Players in United States
    • 5.3 United States Antifungal infection Therapeutics Market Size by Type
    • 5.4 United States Antifungal infection Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Antifungal infection Therapeutics Market Size (2014-2019)
    • 6.2 Antifungal infection Therapeutics Key Players in Europe
    • 6.3 Europe Antifungal infection Therapeutics Market Size by Type
    • 6.4 Europe Antifungal infection Therapeutics Market Size by Application

    7 China

    • 7.1 China Antifungal infection Therapeutics Market Size (2014-2019)
    • 7.2 Antifungal infection Therapeutics Key Players in China
    • 7.3 China Antifungal infection Therapeutics Market Size by Type
    • 7.4 China Antifungal infection Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Antifungal infection Therapeutics Market Size (2014-2019)
    • 8.2 Antifungal infection Therapeutics Key Players in Japan
    • 8.3 Japan Antifungal infection Therapeutics Market Size by Type
    • 8.4 Japan Antifungal infection Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antifungal infection Therapeutics Market Size (2014-2019)
    • 9.2 Antifungal infection Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Antifungal infection Therapeutics Market Size by Type
    • 9.4 Southeast Asia Antifungal infection Therapeutics Market Size by Application

    10 India

    • 10.1 India Antifungal infection Therapeutics Market Size (2014-2019)
    • 10.2 Antifungal infection Therapeutics Key Players in India
    • 10.3 India Antifungal infection Therapeutics Market Size by Type
    • 10.4 India Antifungal infection Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antifungal infection Therapeutics Market Size (2014-2019)
    • 11.2 Antifungal infection Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Antifungal infection Therapeutics Market Size by Type
    • 11.4 Central & South America Antifungal infection Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Scynexis
      • 12.1.1 Scynexis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antifungal infection Therapeutics Introduction
      • 12.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.1.5 Scynexis Recent Development
    • 12.2 Sanofi-Aventis
      • 12.2.1 Sanofi-Aventis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antifungal infection Therapeutics Introduction
      • 12.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.2.5 Sanofi-Aventis Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antifungal infection Therapeutics Introduction
      • 12.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antifungal infection Therapeutics Introduction
      • 12.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Merck & Co
      • 12.5.1 Merck & Co Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antifungal infection Therapeutics Introduction
      • 12.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.5.5 Merck & Co Recent Development
    • 12.6 Kramer Laboratories
      • 12.6.1 Kramer Laboratories Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antifungal infection Therapeutics Introduction
      • 12.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.6.5 Kramer Laboratories Recent Development
    • 12.7 Johnson & Johnson
      • 12.7.1 Johnson & Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antifungal infection Therapeutics Introduction
      • 12.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.7.5 Johnson & Johnson Recent Development
    • 12.8 ID Sigma-Aldrich Corporation
      • 12.8.1 ID Sigma-Aldrich Corporation Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antifungal infection Therapeutics Introduction
      • 12.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.8.5 ID Sigma-Aldrich Corporation Recent Development
    • 12.9 Glenmark Pharmaceuticals
      • 12.9.1 Glenmark Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Antifungal infection Therapeutics Introduction
      • 12.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.9.5 Glenmark Pharmaceuticals Recent Development
    • 12.10 Glaxosmithkline
      • 12.10.1 Glaxosmithkline Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Antifungal infection Therapeutics Introduction
      • 12.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2014-2019)
      • 12.10.5 Glaxosmithkline Recent Development
    • 12.11 Enzon Pharmaceuticals
    • 12.12 Bayer Healthcare
    • 12.13 Astellas Pharma
    • 12.14 Asperqillus
    • 12.15 Alternaria
    • 12.16 Abbott Laboratories

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
      In 2018, the global Antifungal infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Antifungal infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antifungal infection Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Scynexis
      Sanofi-Aventis
      Pfizer
      Novartis
      Merck & Co
      Kramer Laboratories
      Johnson & Johnson
      ID Sigma-Aldrich Corporation
      Glenmark Pharmaceuticals
      Glaxosmithkline
      Enzon Pharmaceuticals
      Bayer Healthcare
      Astellas Pharma
      Asperqillus
      Alternaria
      Abbott Laboratories

      Market segment by Type, the product can be split into
      Polyenes
      Echinocandins
      Azoles
      Allylamines
      Other Drug types

      Market segment by Application, split into
      Powders
      Pastes
      Ointments
      Drugs
      Other Applications

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antifungal infection Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Antifungal infection Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antifungal infection Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now